Switch to:
More From Other Websites
After hours buzz: CSX, UAL, GIMO & more Jan 17 2017
Neurocrine Med Failure, Jazz Pharma Generic Rival OK Sends Both Down Jan 17 2017
Neurocrine Drug Fails to Reduce Tic Severity in Tourette Syndrome Patients Jan 17 2017
Neurocrine Announces Completion of Phase II Clinical Study of VMAT2 Inhibitor INGREZZA™... Jan 17 2017
4:01 pm Neurocrine Biosci announces the top-line results from the Company's Phase II T-Forward study... Jan 17 2017
Here Are Two Market Moving Biotech Catalysts To Watch This Week Jan 17 2017
Neurocrine Biosciences, Inc. – Value Analysis (NASDAQ:NBIX) : January 11, 2017 Jan 11 2017
Neurocrine Biosciences, Inc. breached its 50 day moving average in a Bullish Manner : NBIX-US :... Jan 10 2017
NEUROCRINE BIOSCIENCES INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Jan 06 2017
NBIX: AdComm Meeting for INGREZZA™ Cancelled by FDA Jan 06 2017
What Does The Panel Cancellation Mean For Neurocrine Biosciences, Inc. (NBIX)? Jan 06 2017
These 5 Biotech Stocks Could Be Big Takeover Targets in 2017 Jan 06 2017
Neurocrine Biosciences Announces the Appointment of David-Alexandre Gros M.D. President and Chief... Jan 06 2017
Neurocrine Provides Update on FDA Advisory Committee for INGREZZA™ (valbenazine) for the Treatment... Jan 05 2017
Neurocrine Provides Update on FDA Advisory Committee for INGREZZA™ (valbenazine) for the Treatment... Jan 05 2017
Neurocrine Biosciences to Present at the 35th Annual J.P. Morgan Healthcare Conference Jan 03 2017
7 Key FDA Decisions and Catalysts Expected in January and February Dec 30 2016
NEUROCRINE BIOSCIENCES INC Files SEC form 8-K, Change in Directors or Principal Officers Dec 23 2016
Neurocrine Biosciences Announces Chief Financial Officer Timothy P. Coughlin to Step Down Dec 21 2016
Neurocrine Biosciences Announces Chief Financial Officer Timothy P. Coughlin to Step Down Dec 21 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK